Mitsubishi Chemical Group Corporation Stock

Equities

4188

JP3897700005

Diversified Chemicals

Delayed Japan Exchange 00:13:49 2024-06-19 EDT 5-day change 1st Jan Change
829.1 JPY +2.74% Intraday chart for Mitsubishi Chemical Group Corporation +0.75% -4.10%

Financials

Sales 2024 4,387B 27.79B 38.11B Sales 2025 * 4,622B 29.28B 40.15B Capitalization 1,148B 7.27B 9.97B
Net income 2024 120B 758M 1.04B Net income 2025 * 92.96B 589M 808M EV / Sales 2024 0.73 x
Net Debt 2024 1,906B 12.08B 16.56B Net Debt 2025 * 1,957B 12.4B 17B EV / Sales 2025 * 0.67 x
P/E ratio 2024
10.9 x
P/E ratio 2025 *
12.3 x
Employees 68,639
Yield 2024
3.49%
Yield 2025 *
4%
Free-Float 93.94%
More Fundamentals * Assessed data
Dynamic Chart
Technip Energies to License Improved OXO Alcohol Technology with Mitsubishi Chemical MT
Mitsubishi Chemical Group Disposes 127 Million Yen Worth of Shares as Restricted Compensation MT
Mitsubishi Chemical Group’s Attributable Profit Jumps 24% in Fiscal 2024 MT
Transcript : Mitsubishi Chemical Group Corporation, 2024 Earnings Call, May 15, 2024
Mitsubishi Chemical Group Corporation Provides Earnings Guidance for the First Half and Full Year Ending March 31, 2025 CI
Mitsubishi Chemical Group Corporation Provides Second Quarter End and Fiscal Year End Dividend Guidance for the Fiscal Year Ending March 31, 2025 CI
Mitsubishi Chemical Group Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 4, 2024 CI
AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment AN
Mitsubishi Chemical Group Corporation Appoints Yasuo Shimodaira as Executive Vice President, Head of Basic Materials & Polymers, Effective April 1, 2024 CI
Mitsubishi Chemical Group Corporation Announces Retirement of Kouji Eguchi,Representative Corporate Executive Officer, Effective March 31, 2024 CI
Mitsubishi Chemical Group’s Attributable Profit Surges 509.6% in Fiscal Nine Months MT
Transcript : Mitsubishi Chemical Group Corporation, Q3 2024 Earnings Call, Feb 06, 2024
PsiQuantum, Corp., Mitsubishi UFJ Financial Group, Inc. and Mitsubishi Chemical Announces Partnership to Design Energy-Efficient Materials on PsiQuantum?s Fault-Tolerant Quantum Computer CI
Mitsubishi Chemical Group to Sell 80% Stake in Indonesian Unit for Undisclosed Sum MT
Japan's Nikkei ends higher on US rate cut prospects, shippers fall RE
More news

Latest transcript on Mitsubishi Chemical Group Corporation

1 day+2.68%
1 week+0.75%
Current month-0.25%
1 month-0.77%
3 months-10.80%
6 months-10.66%
Current year-4.10%
More quotes
1 week
795.00
Extreme 795
833.60
1 month
795.00
Extreme 795
850.70
Current year
795.00
Extreme 795
961.20
1 year
795.00
Extreme 795
987.30
3 years
652.60
Extreme 652.6
1 063.00
5 years
543.40
Extreme 543.4
1 063.00
10 years
433.00
Extreme 433
1 319.50
More quotes
Managers TitleAgeSince
Chief Administrative Officer - -
Chief Administrative Officer - -
Director/Board Member 65 14-03-31
Members of the board TitleAgeSince
Director/Board Member 69 16-05-31
Director/Board Member 60 21-03-31
Director/Board Member 63 19-05-31
More insiders
Date Price Change Volume
24-06-19 829.1 +2.74% 4 329 300
24-06-18 807 +0.27% 4,813,500
24-06-17 804.8 -1.29% 5,910,000
24-06-14 815.3 +1.79% 7,747,400
24-06-13 801 -2.60% 6,627,700

Delayed Quote Japan Exchange, June 19, 2024 at 12:13 am

More quotes
Mitsubishi Chemical Group Corporation (formerly Mitsubishi Chemical Holdings Corporation) is a holding company organized around 5 groups of products: - petrochemical products (32.4% of net sales): ethylene, propylene, benzene, coke, ether, etc.; - performance chemicals and materials (28.6%): performance polymers, food ingredients, polyester films, polyvinyl alcohol-based films, water treatment products, carbon fibres and composite materials, etc.; - industrial gases (23.9%); - healthcare products and equipment (10.1%): pharmaceutical products, reagents and diagnostic instruments, active pharmaceutical ingredients, pharmaceutical intermediates, etc.; - other (5%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
807 JPY
Average target price
945.6 JPY
Spread / Average Target
+17.17%
Consensus